Reviva Pharmaceuticals
RVPH
RVPH
23 hedge funds and large institutions have $5.54M invested in Reviva Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
21% more funds holding
Funds holding: 19 → 23 (+4)
1.87% more ownership
Funds ownership: 4.5% → 6.38% (+1.9%)
Holders
23
Holding in Top 10
–
Calls
$1.5M
Puts
$737K
Top Buyers
| 1 | +$293K | |
| 2 | +$286K | |
| 3 | +$255K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$249K |
| 5 |
Two Sigma Investments
New York
|
+$200K |
Top Sellers
| 1 | -$73K | |
| 2 | -$64K | |
| 3 | -$52K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$49.2K |
| 5 |
Jane Street
New York
|
-$27K |